Nimish P. Shah is 10% Owner at KalVista Pharmaceuticals, Inc. (KALV). They have made 8 open-market trades across 5 companies since 2018, most recently 2025-10-10.
CIK 0001698082
8 open-market purchases totalling $46.8M since 2018, never a sale. Across 8 scored buys the stock is down 27.6% at ninety days, and 31.4 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 38% | 13% |
| Avg Move | -13.1% | -15.8% | -27.6% |
| Alpha | -14.8% | -19.9% | -31.4% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALV | BUY | 2024-02-06 | 2024-02-08 | $14.62 | $2.5M | -15.7% | -15.3% | -22.0% |
| KALV | BUY | 2024-01-03 | 2024-01-05 | $12.13 | $1.2M | +6.4% | +35.4% | -4.3% |
| APGE | BUY | 2023-07-13 | 2023-07-17 | $17.00 | $29.8M | +2.4% | +11.5% | -2.1% |
| TCDA | BUY | 2022-10-13 | 2022-10-17 | $11.68 | $4.1M | -96.5% | -98.0% | -98.9% |
| TCDA | BUY | 2022-10-07 | 2022-10-11 | $11.90 | $2.6M | -9.8% | -98.0% | -98.5% |
| TIL | BUY | 2021-03-23 | 2021-03-25 | $20.00 | $6.0M | -6.4% | -30.0% | -26.1% |
| BLPH | BUY | 2019-01-23 | 2019-03-14 | $0.70 | $200K | -7.1% | -7.9% | -9.9% |
| BLPH | BUY | 2018-08-14 | 2018-08-16 | $0.65 | $468K | +21.9% | +76.1% | +41.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.